R2ibf
Manufacturing · Brazil · 11-50 Employees
View Company Info for Free
Overview
Headquarters
376 Avenida José Abbas Casseb, Sao Paulo...Website
www.r2ibf.com.brRevenue
<$5 MillionIndustry
About R2ibf
R2ibf Org Chart
Supervisor De Operação E Manutenção
Is R2ibf your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if R2ibf had a recent Job posting/layoffs
Earning: See what the market has to say on R2ibf recently announced quarterly report
Check out if R2ibf is spiking on competitors!
R2ibf, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at R2ibf
Check if R2ibf has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when R2ibf launches new products
Funding: Get notified immidiatlly once R2ibf has new funding data
Recommended Actions
Find VP level buyers at R2ibf
Find more new buyers
Company Profile Activity
Activity Insights
R2ibf is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
R2ibf is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about R2ibf.
R2ibf Tech Stack
A closer look at the technologies used by R2ibf
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding R2ibf
R2 IBF is a prominent supplier of radiopharmaceuticals for Nuclear Medicine in Brazil, specializing in the production and development of high-quality products for PET-CT diagnostic procedures. Established in February 2019, the company operates four strategically located production plants and is expanding with two new facilities set to open in 2023... Read More